首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Strategies of reducing input sample volume for extracting circulating cell-free nuclear DMA and mitochondrial
【24h】

Strategies of reducing input sample volume for extracting circulating cell-free nuclear DMA and mitochondrial

机译:减少输入样本量以提取循环无细胞核DMA和线粒体的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Circulating cell-free (ccf) DNA in blood has been suggested as a potential biomarker in many conditions regarding early diagnosis and prognosis. However, misdiag-nosis can result due to the limited DNA resources in Biobank's plasma samples or insufficient DNA targets from a predominant DNA background in genetic tests. This study explored several strategies for an efficient DNA extraction to increase DNA amount from limited plasma input. Methods: Ccf plasma DNA was extracted with three different methods, a phenol-chloroform-isoamylalcohol (PCI) method, a High Pure PCR Template Preparation Kit method and a method used for single cell PCR in this group. Subsequently, the total DNA was measured by Nanodrop and the genome equivalents (GE) of the GAPDH housekeeping gene and MTATP 8 gene were measured using a multiplex real-time quantitative PCR for the quantitative assessment of nDNA and mtDNA. Results: Instead of 400-800 muL (routine input in the laboratory), 50 muLof plasma input enabled the extraction of ccf DNA sufficient for quantitative analysis. Using the PCI method and the kit method, both nDNA and mtDNA could be successfully detected in plasma samples, but nDNA extracted using protocol for single cell PCR was not detectable in 25% of plasma samples. In comparison to the other two methods, the PCI method showed lower DNA purity, but higher concentrations and more GE of nDNA and mtDNA. Conclusions: The PCI method was more efficient than the other two methods in the extraction of ccf DNA in plasma. Limited plasma is available for ccf DNA analysis.
机译:背景:在许多有关早期诊断和预后的疾病中,血液中循环的无细胞(ccf)DNA被认为是潜在的生物标记。但是,由于Biobank血浆样品中的DNA资源有限或基因测试中主要DNA背景的DNA靶标不足,可能导致误诊。这项研究探索了几种有效提取DNA的策略,可以从有限的血浆输入中增加DNA量。方法:采用三种不同的方法提取Ccf血浆DNA:苯酚-氯仿-异戊醇(PCI)方法,高纯PCR模板制备试剂盒方法和该组中用于单细胞PCR的方法。随后,通过Nanodrop测量总DNA,并使用多重实时定量PCR测量GAPDH管家基因和MTATP 8基因的基因组当量(GE),以进行nDNA和mtDNA的定量评估。结果:代替400-800μL(实验室常规输入),使用50μL血浆输入可以提取足以定量分析的ccf DNA。使用PCI方法和试剂盒方法,可以成功地在血浆样品中检测到nDNA和mtDNA,但是在25%的血浆样品中检测不到使用单细胞PCR方案提取的nDNA。与其他两种方法相比,PCI方法显示出较低的DNA纯度,但浓度更高,nDNA和mtDNA的GE更高。结论:PCI方法在血浆中CCF DNA的提取中比其他两种方法更有效。有限的血浆可用于ccf DNA分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号